- Morphine
- IV/Subcutaneous/IM (mg)
- PO/Rectal (mg)
- Ratio IV : PO
- Duration of effect
- Long Acting Morphine
- PO/Rectal (mg)
- Duration of effect
- HYDROcodone (Vicodin,Lortab)
- PO/Rectal (mg)
- Duration of effect
- OXYcodone
- PO/Rectal (mg)
- Duration of effect
- Long Acting OXYcodone
- PO/Rectal (mg)
- Duration of effect
- OXYmorphone (Opana)
- IV/Subcutaneous/IM (mg)
- PO/Rectal (mg)
- Ratio IV : PO
- Duration of effect
- Long Acting OXYmorphone
- PO/Rectal (mg)
- Duration of effect
- HYDROmorphone (Dilaudid)
- IV/Subcutaneous/IM (mg)
- PO/Rectal (mg)
- Ratio IV : PO
- Duration of effect
- Fentanyl (See note 3)
- See package insert for conversions involving fentanyl patches.
- Methadone (See note 4)
- Methadone has a complex pharmacokinetic and pharmacodynamic profile that makes equianalgesic dosing particularly difficult. Consult with an experienced clinician before initiating or adjusting the dose of methadone.
- Codeine
- IV/Subcutaneous/IM (mg)
- PO/Rectal (mg)
- Ratio IV : PO
- Duration of effect
- Note
- If converting between opioids when pain is well controlled, decrease the dose of the new opioid by 25-50% to allow for incomplete cross-tolerance. Be prepared to titrate up rapidly for analgesia in the first 24 hrs. If pain is not controlled, you may choose not to decrease the dose.
- Intramuscular administration is discouraged because subcutaneous administration is as effective and less painful.